BACKGROUND: This study was designed to analyze the prognostic significance of the staging system based on the ratio of metastatic lymph nodes (TRM) compared with the TNM staging system in patients with gastric cancer. METHODS: We reviewed the data of 219 patients who underwent gastrectomy for node-positive M0 cancer. Node Ratio (NR) categories (NR1: 1-15%; NR2: 16-40%; NR3: >40%) were determined by the best cutoff approach at log-rank test. After confirming the prognostic validity of NR in a collinearity-free Cox regression analysis, among different combinations of pT and NR categories we selected five prognostically homogeneous TRM classes. To compare the prognostic power of the TRM vs. TNM systems, we plotted TRM and TNM classes against the mortality estimates. RESULTS: Both of the TRM and TNM classifications significantly stratified patients outcomes (p < 0.0001), but the TRM system identified prognostic subgroups more homogeneous than the TNM system. CONCLUSIONS: The TRM staging system is a simple and reliable tool to stratify patients with gastric cancer and has a higher prognostic power than the current system.
BACKGROUND: This study was designed to analyze the prognostic significance of the staging system based on the ratio of metastatic lymph nodes (TRM) compared with the TNM staging system in patients with gastric cancer. METHODS: We reviewed the data of 219 patients who underwent gastrectomy for node-positive M0 cancer. Node Ratio (NR) categories (NR1: 1-15%; NR2: 16-40%; NR3: >40%) were determined by the best cutoff approach at log-rank test. After confirming the prognostic validity of NR in a collinearity-free Cox regression analysis, among different combinations of pT and NR categories we selected five prognostically homogeneous TRM classes. To compare the prognostic power of the TRM vs. TNM systems, we plotted TRM and TNM classes against the mortality estimates. RESULTS: Both of the TRM and TNM classifications significantly stratified patients outcomes (p < 0.0001), but the TRM system identified prognostic subgroups more homogeneous than the TNM system. CONCLUSIONS: The TRM staging system is a simple and reliable tool to stratify patients with gastric cancer and has a higher prognostic power than the current system.
Authors: J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus Journal: N Engl J Med Date: 1999-03-25 Impact factor: 91.245
Authors: Luis F Oñate-Ocaña; Guadalupe Méndez-Cruz; Roberto Hernández-Ramos; Mauricio Becker; José F Carrillo; Roberto Herrera-Goepfert; Vincenzo Aiello-Crocifoglio; Francisco Ochoa-Carrillo; Arturo Beltrán-Ortega Journal: Gastric Cancer Date: 2007-12-25 Impact factor: 7.370
Authors: A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers Journal: Br J Cancer Date: 1999-03 Impact factor: 7.640
Authors: Marco Catarci; Leonardo Antonio Montemurro; Sabrina Ghinassi; Antonio Di Cintio; Leonardo Leone; Luigi Marino Cosentino; Maria Antonietta Viarengo; Giovanni Battista Grassi Journal: Updates Surg Date: 2011-03-29
Authors: Ugwuji N Maduekwe; Gregory Y Lauwers; Carlos Fernandez-Del-Castillo; David L Berger; Charles M Ferguson; David W Rattner; Sam S Yoon Journal: Ann Surg Oncol Date: 2010-01-23 Impact factor: 5.344
Authors: Mario Giuffrida; Lorenzo Viani; Gioacchino Giovanni Iapichino; Federico Cozzani; Paolo Dell'Abate; Paolo Del Rio Journal: Acta Biomed Date: 2021-11-03
Authors: Ali Chehrei; Sakineh Amoueian; Jamshid Ansari; Mehdi Montazer; Mohammad Hossein Sanei Journal: J Res Med Sci Date: 2013-10 Impact factor: 1.852